• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Can we use old NAFLD data under the new MASLD definition?

作者信息

Song Sherlot Juan, Lai Jimmy Che-To, Wong Grace Lai-Hung, Wong Vincent Wai-Sun, Yip Terry Cheuk-Fung

机构信息

Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

J Hepatol. 2024 Feb;80(2):e54-e56. doi: 10.1016/j.jhep.2023.07.021. Epub 2023 Aug 2.

DOI:10.1016/j.jhep.2023.07.021
PMID:37541393
Abstract
摘要

相似文献

1
Can we use old NAFLD data under the new MASLD definition?在新的代谢相关脂肪性肝病（MASLD）定义下，我们能否使用旧的非酒精性脂肪性肝病（NAFLD）数据？
J Hepatol. 2024 Feb;80(2):e54-e56. doi: 10.1016/j.jhep.2023.07.021. Epub 2023 Aug 2.
2
Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes.从非酒精性脂肪性肝病转变为代谢功能障碍相关脂肪性肝病：新定义能够更准确地识别出糖尿病风险较高的个体。
J Hepatol. 2024 Feb;80(2):e85-e87. doi: 10.1016/j.jhep.2023.09.035. Epub 2023 Oct 10.
3
Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease.回复：“从非酒精性脂肪性肝病到代谢相关脂肪性肝病：新定义的前景与陷阱”：欧洲肝脏研究学会（EASL）、美国肝病研究学会（AASLD）和阿卜杜勒阿齐兹国王肝脏研究与移植中心（ALEH）联合起来推动脂肪性肝病领域的发展。
J Hepatol. 2024 Jul;81(1):e20-e21. doi: 10.1016/j.jhep.2023.10.008. Epub 2023 Dec 19.
4
Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD.从非酒精性脂肪性肝病转变为代谢功能障碍相关脂肪性肝病：非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病之间反流性食管炎的累积发病率相似。
Clin Mol Hepatol. 2024 Jan;30(1):121-123. doi: 10.3350/cmh.2023.0437. Epub 2023 Dec 4.
5
[Analysis of non-alcoholic fatty liver disease differences from metabolic dysfunction-associated fatty liver disease based on clinical features].基于临床特征分析非酒精性脂肪性肝病与代谢功能障碍相关脂肪性肝病的差异
Zhonghua Gan Zang Bing Za Zhi. 2024 Apr 20;32(4):346-353. doi: 10.3760/cma.j.cn501113-20231022-00153.
6
From NAFLD to MASLD: When metabolic comorbidity matters.从非酒精性脂肪性肝病到代谢相关性脂肪性肝病：当代谢合并症起重要作用时。
Ann Hepatol. 2024 Mar-Apr;29(2):101281. doi: 10.1016/j.aohep.2023.101281. Epub 2023 Dec 21.
7
MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damage.代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病：对有更高肾脏损伤风险的肥胖儿童的更好定义。
J Hepatol. 2024 Feb;80(2):e87-e89. doi: 10.1016/j.jhep.2023.10.021. Epub 2023 Oct 27.
8
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.代谢相关脂肪性肝病和非酒精性脂肪性肝病的临床特征和病死率相似。
J Hepatol. 2024 May;80(5):694-701. doi: 10.1016/j.jhep.2024.01.014. Epub 2024 Jan 27.
9
Steatotic liver disease, MASLD and risk of chronic kidney disease.脂肪性肝病、MASLD 和慢性肾脏病风险。
Diabetes Metab. 2024 Jan;50(1):101506. doi: 10.1016/j.diabet.2023.101506. Epub 2023 Dec 21.
10
[Diagnosis and evaluation of metabolic dysfunction associated steatotic liver disease (MASLD)].代谢功能障碍相关脂肪性肝病（MASLD）的诊断与评估
Rev Med Interne. 2024 Jan;45(1):41-47. doi: 10.1016/j.revmed.2023.10.438. Epub 2023 Dec 29.

引用本文的文献

1
Quantum chemical optimization and residue-specific stabilization of CDK20 inhibitors in hepatocellular carcinoma.CDK20抑制剂在肝细胞癌中的量子化学优化及残基特异性稳定作用
Mol Divers. 2025 Sep 10. doi: 10.1007/s11030-025-11339-8.
2
Association between air pollution and risk of non-alcoholic fatty liver disease: an updated meta-analysis.空气污染与非酒精性脂肪性肝病风险之间的关联：一项更新的荟萃分析。
Front Public Health. 2025 Aug 19;13:1606959. doi: 10.3389/fpubh.2025.1606959. eCollection 2025.
3
Lipoprotein combine index is associated with non-alcoholic fatty liver disease: a 5-year longitudinal cohort study in non-obese Chinese populations with normal lipids.
脂蛋白综合指数与非酒精性脂肪性肝病相关：一项针对血脂正常的非肥胖中国人群的5年纵向队列研究。
Front Med (Lausanne). 2025 Aug 15;12:1618576. doi: 10.3389/fmed.2025.1618576. eCollection 2025.
4
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状：现有证据综述
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
5
Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals.血清白蛋白与肌酐比值和非酒精性脂肪性肝病之间的关联：一项针对非肥胖中国人群的纵向队列研究。
BMC Gastroenterol. 2025 Aug 27;25(1):620. doi: 10.1186/s12876-025-04201-6.
6
Attributable burden of steatotic liver disease on cardiovascular outcomes in Asia.亚洲脂肪性肝病对心血管结局的归因负担
JHEP Rep. 2025 Jun 6;7(9):101479. doi: 10.1016/j.jhepr.2025.101479. eCollection 2025 Sep.
7
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Characterized by Enhanced Endogenous Cholesterol Synthesis and Impaired Synthesis/Absorption Balance.代谢功能障碍相关脂肪性肝病的特征是内源性胆固醇合成增强以及合成/吸收平衡受损。
Int J Mol Sci. 2025 Aug 1;26(15):7462. doi: 10.3390/ijms26157462.
8
Triglyceride-glucose-waist circumference index: A powerful tool for metabolic dysfunction-associated steatotic liver disease.甘油三酯-血糖-腰围指数：代谢功能障碍相关脂肪性肝病的有力工具。
World J Hepatol. 2025 Jul 27;17(7):107668. doi: 10.4254/wjh.v17.i7.107668.
9
Development of a novel deep learning method that transforms tabular input variables into images for the prediction of SLD.开发一种新型深度学习方法，该方法将表格输入变量转换为图像以预测睡眠呼吸障碍。
Sci Rep. 2025 Jul 31;15(1):28024. doi: 10.1038/s41598-025-12900-z.
10
Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications.基于单体胰高血糖素样肽-1受体激动剂对代谢相关脂肪性肝病及其并发症影响的系统评价。
Diabetol Metab Syndr. 2025 Jul 29;17(1):300. doi: 10.1186/s13098-025-01870-x.